Hormonal replacement therapy duration and its antioxidative effect

Andrzej Pakalski; Grzegorz Stachowiak; Ireneusz Połać; Sławomir Jędrzejczyk; Tomasz Pertyński; Tomasz Stetkiewicz

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2003
vol. 2

Send email

Copy url:

abstract:

Hormonal replacement therapy duration and its antioxidative effect

Andrzej Pakalski

,

Grzegorz Stachowiak

,

Ireneusz Połać

,

Sławomir Jędrzejczyk

,

Tomasz Pertyński

,

Tomasz Stetkiewicz

(Prz Menopauz 2003, 4: 65–69)

Online publish date: 2003/08/27

View full text Get citation

Some effects of HRT may be caused by an antioxidative action of estrogens, which prevent cellular oxidative damage by diminishing the generation of reactive oxygen intermediates (ROI).

Aim of study: Evaluation of hormonal replacement therapy (HRT) antioxidative effect in postmenopausal women in relation to the therapy duration.

Material and methods: Study group consists of 46 postmenopausal women. The mean age was 54.0±5.1 years. ROI generation was evaluated in 20 ml peripheral blood samples. Spontaneous ROI generation and generation after neutrophils activation with stimulators: formyl-metionyl-leucylphenyloalanin (fMLP), phorbol acetate (PMA) and zymosan was measured. As an enhancer of chemiluminescence luminol was used. Chemiluminescency associated with oxydation burst was measured with Luminometr 1251, BioOrbit, Turku, Finland in stable temperature during 30 minutes (15 readings). Measurements were performed before applying continuous estrogen-progestin hormonal replacement therapy, after 3 and 6 months of this therapy.

Results: ROI generation by neutrophils was lower in patients using HRT during 6 months than in the same women after 3 months on this therapy.

Conclusion: The longer the HRT duration, the lower the reactive oxygen intermediates’ generation.

keywords:

Hormonal replacement therapy duration and its antioxidative effect

Andrzej Pakalski , Grzegorz Stachowiak , Ireneusz Połać , Sławomir Jędrzejczyk , Tomasz Pertyński , Tomasz Stetkiewicz

hormonal replacement therapy, reactive oxygen intermediates

Andrzej Pakalski

,

Grzegorz Stachowiak

,

Ireneusz Połać

,

Sławomir Jędrzejczyk

,

Tomasz Pertyński

,

Tomasz Stetkiewicz